Bharat Shah, Hiren Ved on sectors to bet on for this decade

Bharat Shah, executive director at ASK Group and a mentor to many on Dalal Street, said the financial services sector in the country has a “huge, huge opportunity” to grow over the coming decade as the economy develops. Shah said he was hopeful of...

Getty Images
Over the course of the past year, domestic investors have been growing optimistic on the prospects for the Indian economy in the new decade.
MUMBAI – With the Indian corporate sector recovering faster than expected from the pandemic, along with cleaner and leaner balance sheets, several veteran investors are betting on a new era of corporate profit growth.

Veteran investors like Bharat Shah and Hiren Ved were recently asked — at PMSBazaar’s PMS-AIF Summit 2021 — to enlist a few sectors that they believe would be ahead of the rest in the 2020s.

Bharat Shah, executive director at ASK Group and a mentor to many on Dalal Street, said the financial services sector in the country has a “huge, huge opportunity” to grow over the coming decade as the economy develops. Shah said he was hopeful of the prospects of the country’s pharmaceutical and healthcare services companies as well as insurance. The three sectors have had a rejuvenation during the Covid-19 era as people have realised the importance of having a proper healthcare system and insurance cover.


Shah said the government’s production-linked incentive scheme could lead to the renaissance of the Indian manufacturing industry and that he was also positive on the chemical and IT sector.

Over the course of the past year, domestic investors have been growing optimistic on the prospects for the Indian economy in the new decade. The previous decade suffered several rude shocks on the economic front. The stock market itself did not have much to celebrate given its underperformance against developed markets like the US.

On Dalal Street, there is a general consensus that the Indian economy may exit the decade at more than a $6-trillion opportunity as private capital expenditure, middle-class spending and manufacturing sector pick up.
ADVERTISEMENT

At the PMSBazaar’s PMS-AIF Summit 2021, Hiren Ved, CEO, director and CIO at Alchemy Capital, said he would be betting his money on sectors that have had a proven track record of developing competitive edge at a global level. He contined to back information technology, pharmaceutical and light engineering good manufacturers. “Good, well-run businesses that focus on consumer discretionary products will do very well,” said Ved.

The veteran investor was also confident that good lending institutions in the financial services sector would do good in this decade.

TCS, Tech Mahindra among 7 stock ideas that may help you beat market volatility
1/8

The stock market is swinging between hopes and fears over the rapid spread of the Omicron variant in India and across the world. But amid the wild moves, there are ample opportunities for traders to eke out some solid short-term gains. Analysts recommend seven such trades:

The stock market is swinging between hopes and fears over the rapid spread of the Omicron variant in India and across the world. But amid the wild moves, there are ample opportunities for traders to ..
Read More

Recently, the stock corrected from a high of Rs 3,990 and found support near Rs 3,385 level, which was close to the 50-week SMA. Technical indicators are giving positive signals as the stock is trading above its 20-day and 50-day SMA. Momentum readings like the 14-day RSI too are in a rising mode and not overbought, which implies potential for further upsides. With the intermediate technical setup looking positive, we recommend a buy between Rs 3,630-3,650 levels. Keep a stop loss at Rs 3,400 for a target of Rs 4,200.



(Subash Gangadharan, Senior Technical and Derivative Analyst, HDFC Securities)

Recently, the stock corrected from a high of Rs 3,990 and found support near Rs 3,385 level, which was close to the 50-week SMA. Technical indicators are giving positive signals as the stock is tradi..
Read More

Recently, the stock was consolidating in a tight range between Rs 285-351 levels before breaking out on Friday on the back of above average volumes. With the stock trading above key moving averages like the 20-day SMA and 200-day EMA, the intermediate technical setup looking positive and momentum readings like the 14-day RSI in rising mode and not overbought, the uptrend looks set to continue. We, therefore, recommend a buy between Rs 348-354 levels. Stop loss should be at Rs 321 while the target is at Rs 420.



(Subash Gangadharan, Senior Technical and Derivative Analyst, HDFC Securities)

Recently, the stock was consolidating in a tight range between Rs 285-351 levels before breaking out on Friday on the back of above average volumes. With the stock trading above key moving averages l..
Read More

Tech Mahindra has formed higher bottom formation post short-term correction. Currently, the stock is trading near its all-time high levels and the texture of the chart suggests strong possibility of fresh breakout in the near term. We are of the view that 20-day SMA or Rs 1,538 would act as a key support level and stop loss. Unless the counter is trading below Rs 1,538, positional traders retain an optimistic stance and look for a target of Rs 1,700. Fresh buying can be considered now and on dips, if any, between Rs 1,600 and 1,575.



(Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities)

Tech Mahindra has formed higher bottom formation post short-term correction. Currently, the stock is trading near its all-time high levels and the texture of the chart suggests strong possibility of ..
Read More

From the level of Rs 4,075 the stock witnessed short term-price correction. The stock corrected over 10 per cent from the level of Rs 4,075. After a sharp fall, it finally took support near Rs 3,600 and reversed sharply. Momentum indicators and reversal formation indicate strong possibility of one more uptrend rally if it succeeds to trade above Rs 3,665 support level. For positional traders, Rs 3,665 would act as a sacrosanct support level and stop loss. Above the same, the uptrend formation will continue up to Rs 4,065.



(Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities)

From the level of Rs 4,075 the stock witnessed short term-price correction. The stock corrected over 10 per cent from the level of Rs 4,075. After a sharp fall, it finally took support near Rs 3,600 ..
Read More

After a short-term price correction, the stock took support near its 50-day SMA. It has been consistently taking support between Rs 160 and Rs 165. On daily charts, the stock has formed higher bottom formation which indicates strong possibility of fresh uptrend from current levels. For positional traders, Rs 164.80 would be the stop loss and target at Rs 182.



(Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities)

After a short-term price correction, the stock took support near its 50-day SMA. It has been consistently taking support between Rs 160 and Rs 165. On daily charts, the stock has formed higher bottom..
Read More

The price decline in the stock has been gradual in nature and in the process, formed a ‘Downward Sloping Channel’ where both ends of this pattern were tested on multiple occasions. Now stock prices have reached a cluster of support where multiple technical evidences converge. Hence, there is a possibility of the recent corrective phase getting completed and the stock may move upwards from here. We recommend buying around Rs 143 for a trading target of Rs 152. A stop loss can be placed at Rs 139.



(Sameet Chavan, Angel One)

The price decline in the stock has been gradual in nature and in the process, formed a ‘Downward Sloping Channel’ where both ends of this pattern were tested on multiple occasions. Now stock prices h..
Read More

During the week, Sun Pharma shares slipped below its daily 89-EMA which had provided rock solid support on numerous occasions of late. Thus, we expect this weakness to persist in the counter. One can look to short in a range of Rs 757-759 for a near-term target of Rs 735. A stop loss can be placed at Rs 772.



(Sameet Chavan, Angel One)

During the week, Sun Pharma shares slipped below its daily 89-EMA which had provided rock solid support on numerous occasions of late. Thus, we expect this weakness to persist in the counter. One can..
Read More

ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › News › Bharat Shah, Hiren Ved on sectors to bet on for this decade
Text Size:AAA
Success
This article has been saved

*

+